Post-Event Recap: MyNM FOCUS 1.0 2026 Sets New Benchmark in Nuclear Medicine & PSMA Theragnostics

The MyNM FOCUS 1.0 2026 forum (July 6–7, 2026) successfully wrapped up at Institut Kanser Negara and the Medical Academies of Malaysia, delivering two dynamic days of hands-on skill-building and clinical updates in nuclear medicine. Organised in collaboration with IKN’s Department of Nuclear Medicine and Novartis, the event featured practical masterclasses on Ga-68 and F-18 PSMA PET-CT reporting, facility walkthrough tours, radiation safety, and cutting-edge keynotes on advanced prostate cancer theragnostics from global leaders like Prof. Dr. Scott Tagawa and Prof. Dr. Wolfgang Fendler—marking a major step forward for precision radiopharmaceutical practice in the region.